Insulet reported a higher-than-expected profit in the fourth quarter on Thursday, driven by strong demand for its wearable insulin pumps.

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

Insulin pump therapy, also known as continuous subcutaneous ... Boehringer Ingelheim, and Lilly through institutional research grants. R.W.H. has not received any personal honoraria.

Genetic engineering deployed to insert gene for human insulin into a bacterium, thus harnessing the substance for widespread use ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Lilly has taken a non-exclusive license to deploy Dexcom’s CGM systems – which include app-based remote monitoring and alarm functions – in pen- and pump-based insulin systems that form the ...

The platform could provide an alternative to the "artificial pancreas" systems, which use glucose-sensing devices coupled with insulin pumps. Lilly would likely have been right at the top of the ...

The settlement requires Novo Nordisk to offer its insulin products ... reached with Eli Lilly and Sanofi. 13 Noodle Recipes to Celebrate Chinese New Year Tesla's Heat Pump: A Game-Changer for ...

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest insulin makers of charging astronomically high prices for the diabetes ...

The global Insulin Delivery Devices Market was valued at USD 30.9 billion in 2022 and is expected to grow significantly, ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline. Click for my LLY stock update.

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...